• Nirmatrelvir

    Nirmatrelvir

    API’s Name Indication Innovator Patent Expiry Date(The U.S)
    Nirmatrelvir 3C-Like Protease (3CLPRO) Inhibitor And SARS-Cov-2 Mpro Inhibitor    

     

  • Niraparib 1038915-60-4

    Niraparib 1038915-60-4

    API’s Name Indication Innovator Patent Expiry Date(The U.S)
    Niraparib 1038915-60-4 Ovarian/Fallopian,tube/primary  peritoneal cancer Tesaro Jan.8, 2028